| Metric | Q4 2020 | Q3 2020 | Q4 2019 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $189M | $123M | — | 54.0% | — |
| Op. Income | $8M | $2M | — | 433.2% | — |
| Gross Margin | 23.5% | 31.0% | — | -7.5pp | — |
| Net Margin | 1.5% | -0.9% | — | 2.4pp | — |
| EPS (Diluted) | $0.03 | $-0.01 | — | 396.2% | — |
| Free Cash Flow | $137M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $189M |
| Cost of Revenue | $145M |
| GROSS PROFIT | $44M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $24M |
| SG&A Expenses | $24M |
| Other Expenses | $12M |
| Operating Expenses | $36M |
| Cost & Expenses | $181M |
| OPERATING INCOME | $8M |
| Interest Income | $0 |
| Interest Expense | $4M |
| Other Income/Expenses | -$4M |
| INCOME BEFORE TAX | $4M |
| Income Tax Expense | $935.0K |
| Net Income from Continuing Ops | $3M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $3M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $3M |
| D&A | $4M |
| EBIT | $8M |
| EBITDA | $12M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $189M |
| Cost of Revenue | $145M |
| GROSS PROFIT | $44M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $24M |
| SG&A Expenses | $24M |
| Other Expenses | $12M |
| Operating Expenses | $36M |
| Cost & Expenses | $181M |
| OPERATING INCOME | $8M |
| Interest Income | $0 |
| Interest Expense | $4M |
| Other Income/Expenses | -$4M |
| INCOME BEFORE TAX | $4M |
| Income Tax Expense | $935.0K |
| Net Income from Continuing Ops | $3M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $3M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $3M |
| D&A | $4M |
| EBIT | $8M |
| EBITDA | $12M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $3M |
| Depreciation & Amortization | $4M |
| Stock-Based Compensation | $6M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $5M |
| Change in Working Capital | $119M |
| OPERATING CASH FLOW | $138M |
| Capital Expenditure | -$557.0K |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$557.0K |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$200.0K |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | -$200.0K |
| FREE CASH FLOW | $137M |
| Net Change in Cash | $143M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $1M |
| Short-Term Investments | $0 |
| Net Receivables | $0 |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $1M |
| PP&E (Net) | $0 |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $230M |
| Tax Assets | $0 |
| Other Non-Current Assets | $0 |
| TOTAL NON-CURRENT ASSETS | $230M |
| TOTAL ASSETS | $231M |
| Account Payables | $0 |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $793.0K |
| TOTAL CURRENT LIABILITIES | $793.0K |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $27M |
| TOTAL NON-CURRENT LIABILITIES | $27M |
| TOTAL LIABILITIES | $28M |
| Common Stock | $198M |
| Additional Paid-In Capital | $10M |
| Retained Earnings | -$5M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $203M |
| Minority Interest | $0 |
| TOTAL EQUITY | $203M |
| TOTAL LIABILITIES & EQUITY | $231M |
| Total Debt | $0 |
| Net Debt | -$1M |
